What Is Cetirizine?
Cetirizine is a second-generation antihistamine (H1 receptor antagonist) widely used for the treatment of allergic rhinitis (seasonal and perennial), allergic conjunctivitis, and chronic urticaria (hives). It is the active metabolite of hydroxyzine and was developed in the 1980s. Cetirizine is known for its rapid onset of action (within one hour) and potent antihistamine activity. It is available over-the-counter under brand names such as Zyrtec, and as a generic medication worldwide.
What Is Loratadine?
Loratadine is another second-generation antihistamine, marketed under the brand name Claritin and widely available as a generic. It was approved by the FDA in 1993 and is one of the most commonly used non-sedating antihistamines. Loratadine is a prodrug that is converted to its active metabolite, desloratadine, in the liver. It has a slightly different receptor binding profile compared to cetirizine, which may account for differences in efficacy and side effect profile between the two drugs.
Mechanism of Action: How Antihistamines Work
Both cetirizine and loratadine are selective inverse agonists at the histamine H1 receptor. By binding to and stabilizing the inactive conformation of the H1 receptor, they prevent histamine from exerting its effects on target tissues, including vascular endothelium (vasodilation, increased permeability), smooth muscle (bronchoconstriction), and sensory nerve endings (itching, sneezing). Unlike first-generation antihistamines (diphenhydramine, chlorpheniramine), both drugs have limited penetration into the central nervous system due to their molecular structure and P-glycoprotein efflux, resulting in significantly less sedation.
Cetirizine has approximately 100-fold higher affinity for the H1 receptor compared to loratadine in vitro, though the clinical significance of this difference varies between individuals. Cetirizine is not extensively metabolized and is primarily excreted unchanged in the urine, whereas loratadine undergoes hepatic metabolism via CYP3A4 and CYP2D6 to its active metabolite desloratadine.
Approved Uses and Indications
| Condition | Cetirizine | Loratadine | Evidence Level |
|---|---|---|---|
| Seasonal Allergic Rhinitis (hay fever) | ✅ First-line | ✅ First-line | Strong (multiple RCTs) |
| Perennial Allergic Rhinitis | ✅ Recommended | ✅ Recommended | Strong |
| Allergic Conjunctivitis | ✅ Effective | ✅ Effective | Moderate |
| Chronic Urticaria (hives) | ✅ First-line | ✅ Recommended | Strong (EAACI/GA²LEN guidelines) |
| Acute Urticaria | ✅ Effective | ✅ Effective | Moderate |
| Atopic Dermatitis (adjunct) | ✅ May help pruritus | ✅ May help pruritus | Limited |
Dosage Comparison
| Parameter | Cetirizine | Loratadine |
|---|---|---|
| Adult Dose | 10 mg once daily | 10 mg once daily |
| Children (6–12 years) | 5–10 mg once daily | 10 mg once daily |
| Children (2–6 years) | 2.5–5 mg once daily | 5 mg once daily |
| Onset of Action | Within 1 hour | 1–3 hours |
| Peak Effect | 4–6 hours | 4–6 hours |
| Duration of Action | 24 hours | 24 hours |
| Half-Life | 8–11 hours | 8–14 hours (active metabolite 17–24 h) |
| Metabolism | Minimal (mostly renal excretion) | Hepatic (CYP3A4) |
| Renal Adjustment (CrCl <30 mL/min) | 5 mg once daily | 10 mg every other day |
| Hepatic Adjustment | 5 mg once daily | 10 mg every other day |
Side Effects Comparison
| Side Effect | Cetirizine | Loratadine | Notes |
|---|---|---|---|
| Sedation / drowsiness | Mild (5–10%) | Minimal (1–3%) | Cetirizine slightly more sedating at standard doses |
| Headache | 2–5% | 2–5% | Similar incidence |
| Dry mouth | 2–5% | 1–3% | Both relatively low |
| Fatigue | 3–6% | 1–3% | Cetirizine slightly higher |
| Dizziness | 1–3% | 1–2% | Similar |
| GI upset (nausea, diarrhea) | 1–2% | 1–3% | Similar |
| Pharyngitis | 1–2% | 1–3% | Similar |
Which Is More Effective?
Head-to-head clinical trials consistently show that cetirizine has a slightly faster onset of action and greater suppression of histamine-induced wheal-and-flare reactions compared to loratadine. A randomized, double-blind, placebo-controlled study by Day et al. (2001) in the Journal of Allergy and Clinical Immunology found that cetirizine 10 mg provided significantly greater relief of seasonal allergic rhinitis symptoms within the first 24 hours compared to loratadine 10 mg. However, by day 3–5 of treatment, the differences between the two drugs were minimal.
For chronic urticaria, cetirizine has been more extensively studied and is often considered marginally more effective, particularly for itch reduction. The EAACI/GA²LEN/EDF/WAO guidelines for urticaria recommend both as first-line therapy, with cetirizine having a slightly stronger recommendation based on the available evidence base.
The most clinically meaningful difference is sedation: loratadine causes significantly less sedation than cetirizine at standard doses. For patients who need to operate machinery, drive, or work in safety-sensitive environments, loratadine may be the preferred choice.
Drug Interactions
Cetirizine has very few drug interactions because it undergoes minimal hepatic metabolism. Loratadine is metabolized by CYP3A4; therefore, strong CYP3A4 inhibitors (clarithromycin, erythromycin, ketoconazole, ritonavir) can increase loratadine concentrations, though this is rarely clinically significant due to loratadine’s wide therapeutic index. Conversely, CYP3A4 inducers may theoretically reduce loratadine efficacy. Cetirizine’s lack of significant CYP interactions makes it preferable in patients on multiple medications.
India Generic Pricing
Both cetirizine and loratadine are available as affordable generics in India. Below are approximate price ranges for Indian generic formulations.
| Medication | Strength | Indian Generic Price (per 10 tablets) | US Brand Price Comparison |
|---|---|---|---|
| Cetirizine (generic) | 10 mg | ₹5–₹8 ($0.06–$0.10) | $10–$25 (Zyrtec®, 30 tablets) |
| Loratadine (generic) | 10 mg | ₹4–₹6 ($0.05–$0.07) | $8–$20 (Claritin®, 30 tablets) |
| Cetirizine + Pseudoephedrine | 5/120 mg | ₹12–₹18 ($0.14–$0.22) | $15–$30 (Zyrtec-D®) |
| Loratadine + Pseudoephedrine | 5/120 mg | ₹10–₹15 ($0.12–$0.18) | $12–$25 (Claritin-D®) |
Note: Prices are approximate and may vary by pharmacy, location, and quantity. For current pricing, browse our generic allergy medications.
Frequently Asked Questions
Special Populations
Pregnancy: Both cetirizine (FDA Category B) and loratadine (FDA Category B) are generally considered safe during pregnancy, though no antihistamine should be used routinely without medical consultation. Loratadine has somewhat more extensive safety data in pregnancy. Breastfeeding: Both drugs are excreted in breast milk in low concentrations and are generally compatible with breastfeeding. Renal impairment: Cetirizine requires dose adjustment (5 mg daily) for patients with CrCl below 30 mL/min. Loratadine dosing should be reduced to 10 mg every other day. Hepatic impairment: Both require dose adjustment in severe hepatic disease.
Clinical Evidence Summary
A meta-analysis of 12 randomized controlled trials comparing second-generation antihistamines for seasonal allergic rhinitis found that cetirizine was associated with a statistically significant greater reduction in total symptom scores compared to loratadine on day 1 of treatment, though the difference was small (standardized mean difference 0.15, 95% CI 0.05–0.25). By day 3–5, no significant difference was observed. For quality of life measures, both drugs showed similar improvements.
For chronic urticaria, a Cochrane review (2013) found that cetirizine and loratadine were both superior to placebo, with cetirizine showing a slightly higher responder rate for complete symptom resolution. However, head-to-head trials were limited, and the quality of evidence was moderate.
Conclusion: How to Choose
The choice between cetirizine and loratadine depends on individual patient factors. Patients who need rapid symptom relief, particularly during acute allergy flares, may prefer cetirizine. Those who prioritize minimal sedation and have no contraindications to hepatic metabolism may prefer loratadine. For chronic urticaria, cetirizine has a slightly stronger evidence base. Both are excellent, affordable options for managing allergic conditions, and the affordable generic versions available from Indian manufacturers make them accessible to most patients.
Medical Disclaimer: This article provides general information for educational purposes only. It does not constitute medical advice. Always speak with a healthcare professional before starting any new medication. Price ranges are estimates and may vary.
References
- Day JH, et al. “Efficacy and safety of cetirizine vs loratadine in patients with seasonal allergic rhinitis.” J Allergy Clin Immunol. 2001;107(2):S236.
- Zuberbier T, et al. “The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.” Allergy. 2018;73(7):1393-1414.
- Meltzer EO, et al. “Treating allergic rhinitis: comparing intranasal corticosteroids and oral antihistamines.” J Allergy Clin Immunol. 2009;124(6):1160-1167.
- Simons FER, Simons KJ. “Histamine and H1-antihistamines: celebrating a century of progress.” J Allergy Clin Immunol. 2011;128(6):1139-1150.
- Church MK, et al. “Risk of sedation with H1 antihistamines.” Clin Exp Allergy. 2010;40(3):468-475.
- Ferrer M, et al. “Management of urticaria: an update on current guidelines.” Allergy. 2020;75(7):1771-1773.
- FDA Prescribing Information: Zyrtec (cetirizine HCl). Revised 2019.
- FDA Prescribing Information: Claritin (loratadine). Revised 2020.
- UpToDate. “Pharmacotherapy of allergic rhinitis.” Accessed July 2026.
